Tumorous neo-vascularization: a newly recognized endoscopic feature of intestinal non-Hodgkin lymphoma.
نویسندگان
چکیده
Endoscopic features of intestinal lympho− ma usually comprise infiltration of the intestinal wall: the affected segment is ri− gid, reddish, fragile, and often bleeds spontaneously. Irregular nodular pattern and multiple ulcers with scaring may also be found [1± 3]. We report two cases of macroscopically visible neo−vasculari− zation as a newly recognized endoscopic feature of intestinal lymphoma. We con− sider these pathological, winding, tortu− ous vessels as a unique sign of tumorous angiogenesis. We can hypothesize that this could be stimulated by means of cy− tokines mediated by T−lymphocytes infil− trating margins of the neoplasm. Another possible factor is the bcl−2 family of pro− teins, which are considered to be respon− sible for pathological neo−vascularization in both human and experimental oncolo− gy [4,5]. In both our cases, B−lymphocytes also expressed bcl−2 proteins in the lym− phoma.
منابع مشابه
Unusual Presentation of T-cell non-Hodgkin Lymphoma with Multiple Skin Nodules
Non-Hodgkin lymphoma is very uncommon in infancy and skin as the primary site of involvement in Non-Hodgkin lymphoma is rarely encountered. We describe a 10-month-old infant with T-cell Non-Hodgkin lymphoma who presented with multiple skin nodules as the predominant feature of her disease. The clinical manifestations, treatment strategy and disease outcome are reviewed. Key words: Non-Hodgk...
متن کامل18F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases
Neurolymphomatosis is a rare manifestation of non-Hodgkin lymphoma characterized by infiltration of peripheral nerves, nerve roots, plexus and cranial nerves by malignant lymphocytes. This report presents positron emission tomography/computed tomography (PET/CT)imaging with 2-deoxy-2-18F-fluoro-D-glucose (18F-FDG) in 3 cases of non-Hodgkin lymphoma with nerve infiltration, including one newly d...
متن کاملDevelopment of DOTA-Rituximab kit formulation to be labeled with 90Y for radioimmunotherapy of B-cell Non-Hodgkin Lymphoma
NHL is the most common hematologic cancer in adults. Rituximab is the FDA approved treatment of relapsed or refractory low grade B-cell Non-Hodgkin Lymphoma (NHL). But patients eventually become resistant to rituximab. Since lymphocytes and lymphoma cells are highly radiosensitive, low grade NHL that has relapsed or refractory to standard therapy is treated by RIT in which a beta-emitting radio...
متن کاملDevelopment of DOTA-Rituximab kit formulation to be labeled with 90Y for radioimmunotherapy of B-cell Non-Hodgkin Lymphoma
NHL is the most common hematologic cancer in adults. Rituximab is the FDA approved treatment of relapsed or refractory low grade B-cell Non-Hodgkin Lymphoma (NHL). But patients eventually become resistant to rituximab. Since lymphocytes and lymphoma cells are highly radiosensitive, low grade NHL that has relapsed or refractory to standard therapy is treated by RIT in which a beta-emitting radio...
متن کاملChylous pleural effusion: A rare presentation of Non-Hodgkin- Lymphoma
Chylous pleural effusion is characterized by milky-appearing fluid with elevated triglyceride content and presence of chylomicrons in the pleural space. Even though patients with lymphoma sometimes present with malignant pleural effusion, chylous effusion is rarely encountered as a presenting feature in such patients. We present a 47-year-old woman diagnosed as follicular lymphoma who presented...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Endoscopy
دوره 39 Suppl 1 شماره
صفحات -
تاریخ انتشار 2007